Page 54 - CIBERESP2016-ENG

lEaD rESEarCHEr
Castilla Catalán, Jesús
Instituto de Salud Pública de Navarra
Leyre, 15
31003 Pamplona | Navarra
(+34) 848 421 477 [email protected] group website
GROUP MEMBERS
Staff members: Burgui Pérez, Rosana | Delfrade Osinaga, Iosu | Etxebarría Andueza, Jaione | Juanbeltz Zurbano, Regina | Miqueleiz Autor, Estrella | Pérez García, Alejandra
Associated members: Ardanaz Aicua, Eva | Arriazu Berastegui, María Teresa | Ascunce Elizaga, Nieves
| Barricarte Gurrea, Aurelio | Casado Buesa, Marina Itziar | Echauri Ozcoidi, Marga | Ederra Sanz, María | Erdozain Eguaras, Nieves | Floristán Floristán, María del Yugo | García Cenoz, Manuel | Guevara Eslava, Marcela del Pilar | Marín Palacios, Pilar | Martínez Baz, Iván | Vidán Alli, Juana
Main lines of research
• Epidemiology of chronic diseases, by participation in multicenter cohort studies and in population- based registers of cancer and acute myocardial infarction.
- Cohort EPIC and associated projects EPIC-Heart, InterAct and Neuro-EPIC.
- Multicase-Control Study MCC-Spain
- Spanish Network of Population-based Cancer Registries REDECAN.
- Cardiovascular diseases and participation in the study FRESCO.
- Analysis of mortality, trends and analysis of socioeconomic inequalities (MEDEA). - Studies on lifestyles and health.
- Rare Diseases Registry.
• Evaluation of screening programmes.
- Impact of breast cancer screening programmes.
- Analysis of the probability of false-positive results in screening mammography.
- Relationship among false-positive, true positive and adherence to the screening programmes.
- Mammographic breast density in Spanish women coming to breast cancer screening programmes (DDM-Spain) and association with reproductive & lifestyle factors & genetic determinants (Var-DDM).
• Epidemiological research on infectious diseases and evaluation of the effectiveness and impact of the vaccines:
- Effectiveness and impact of vaccines: influenza, pneumococcal, varicella, rotavirus, mumps, whooping cough, meningogocal, etc.
- Investigation of infectious diseases outbreaks.
- Evaluation of preventive interventions against HIV, tuberculosis, etc.
- Evaluation of the National Stretegic Program against Hepatitis C infection.
54
PROGRAMME
Epidemiology and Prevention of Chronic Diseases